
House Bill Would Delay Hemp Definition Changes Until 2027
Bipartisan measure seeks two-year extension as industry scrambles to adapt to new restrictions
A bipartisan House bill introduced Tuesday would push back enforcement of controversial hemp definition changes until 2027, giving the industry breathing room as it grapples with new federal restrictions on intoxicating cannabinoid products.
Rep. Jim Baird (R-IN) filed the legislation to extend hemp provisions currently set to take effect far sooner under the Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations bill. Those provisions narrowed the legal definition of hemp in ways that could eliminate many products currently on store shelves.
"Planting and growing crops takes time and planning," Baird said in a statement announcing the bill. The Indiana Republican's measure has attracted support from both sides of the aisle, though the full list of co-sponsors wasn't immediately available.
What's at Stake
The appropriations bill language at issue redefines legal hemp to exclude products containing intoxicating amounts of delta-8 THC, delta-9 THC, and other psychoactive cannabinoids derived from hemp. Under current federal law, hemp is defined as cannabis containing no more than 0.3% delta-9 THC by dry weight—a standard that has allowed manufacturers to produce a range of intoxicating products through chemical conversion and concentration processes.
Industry analysts estimate the hemp-derived cannabinoid market generates several billion dollars in annual sales through gas stations, smoke shops, and online retailers. Many of these products exist in a regulatory gray area, marketed as legal alternatives to state-licensed marijuana.
The definitional change would effectively eliminate this market segment unless Congress acts. Farmers who have planted hemp specifically for cannabinoid extraction face potential losses if the restrictions take effect before they can pivot their operations.
Industry Pushback
Hemp industry groups have lobbied intensively against the restrictions since they first appeared in appropriations negotiations last year. They argue the changes amount to a de facto ban on hemp-derived products without proper regulatory process or industry input.
Critics of the hemp-derived THC market, however, say the products circumvent state marijuana programs and lack proper testing and labeling requirements. Several states have moved independently to restrict or ban intoxicating hemp products, citing concerns about youth access and product safety.
Timeline and Next Steps
The two-year extension would give federal regulators time to develop a comprehensive framework for hemp-derived cannabinoids rather than implementing restrictions through appropriations language. It would also allow farmers to adjust planting decisions and manufacturers to reformulate products or wind down operations.
The bill faces an uncertain path in a narrowly divided House, and its prospects in the Senate remain unclear. Agricultural committees in both chambers are also working on the next Farm Bill, which could address hemp regulation more comprehensively.
Baird's office didn't respond to questions about whether the extension would include any new regulatory requirements or simply maintain the status quo for two additional years.
The hemp industry has argued it needs clear, science-based regulations rather than shifting definitions in spending bills. But with federal marijuana rescheduling proceedings stalled and comprehensive cannabis reform legislation going nowhere, appropriations measures have become the primary vehicle for hemp policy changes.
This article is based on original reporting by ganjapreneur.com.
Original Source
This article is based on reporting from Ganjapreneur.
Read the original articleOriginal title: "Federal Proposal Seeks to Delay Incoming Hemp Product Crackdown"
Related Topics
Related Stories
LegislationConnecticut Expands Psychedelics Pilot as FDA Decision Looms
Connecticut's Joint Committee on Public Health advanced legislation expanding the state's psychedelic therapy pilot program to include first responders, as lawmakers prepare for potential FDA approval of MDMA and psilocybin treatments.
LegislationRescheduling Won't Fix Cannabis Industry Without Insurance Access
Cannabis industry experts argue Trump's rescheduling order won't stabilize the market without insurance reimbursement access, which matters more than tax relief for long-term viability.
LegislationLaw Enforcement Coalition Pushes Congress to Uphold Hemp THC Ban
Law enforcement groups are urging Congress to let a federal ban on hemp-derived THC products take effect, opposing industry efforts to delay recriminalization of delta-8 and similar compounds that generate billions in annual sales.
More from David Okonkwo
View all articles
Connecticut Expands Psychedelics Pilot as FDA Decision Looms

Virginia Moves Closer to Legal Cannabis Sales After House, Senate Votes

California Cannabis Packaging Rules Face Industry Scrutiny

